FDA Clearance Tracker · P010014-S105
Oxford Cementless Partial Knee System
Last checked: Nov 20, 2026Latest source record: Nov 22, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 22, 2024
Approved
Time to decision
536 days
Received Jun 5, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P010014-S105
- Device name
- Oxford Cementless Partial Knee System
- Applicant
- Biomet Manufacturing Corp
- Applicant location
- Warsaw, IN
- Received
- Jun 5, 2023
- Decided
- Nov 22, 2024
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P010014
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The Oxford Cementless Partial Knee System is indicated for use in unilateral knee procedures with osteoarthritis or avascular necrosis limited to the medial compartment of the knee. It is intended to be implanted without the application of bone cement for patients whose clinical condition would benefit from a shorter surgical time compared to the cemented implant.
Source documents
Other decisions for Biomet Manufacturing Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K230540 · Decided Jul 25, 2023 · 148 days after receipt
Device type: System, Image Processing, Radiological (LLZ) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.